News
Engineered helper T cells targeting MAGE-A3 produced some clinical responses
- Author:
- Daniel M. Keller
Publish date: April 18, 2016
Key clinical point: Engineered helper T cells safely target tumors and produce clinical responses. Major finding: Three of 14 patients with...
News
Study found long-term benefit of nivolumab for advanced melanoma patients
- Author:
- Daniel M. Keller
Publish date: April 18, 2016
Key clinical point: Heavily pretreated patients with advanced melanoma had long-term responses on nivolumab monotherapy. Major finding: Nivolumab...